Cardio Diagnostics Holdings, Inc.
CDIONasdaqCIK 1870144HealthcareFiscal year ends Dec 31
Reports and events: 76 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-01-1316:36 ET | S-1/A | Registration statement, amended | 0001136261-23-000014 |
| 2022-12-2716:36 ET | S-1/A | Registration statement, amended | 0001136261-22-000391 |
| 2022-12-1216:36 ET | S-1 | Registration statement | 0001136261-22-000381 |
| 2022-11-1016:26 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001079973-22-001417 |
| 2022-11-0716:13 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001079973-22-001398 |
| 2022-11-0413:43 ET | SC 13D | Ownership report, active investor | 0000935836-22-000585 |
| 2022-11-0317:12 ET | SC 13D | Ownership report, active investor | 0000935836-22-000580 |
| 2022-10-3116:36 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-22-001382 |
| 2022-09-2317:02 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001079973-22-001157 |
| 2022-09-2108:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-22-001136 |
| 2022-09-1516:50 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001079973-22-001114 |
| 2022-08-2616:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-22-001040 |
| 2022-08-2517:05 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001079973-22-001032 |
| 2022-08-1016:32 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001079973-22-000958 |
| 2022-05-3117:03 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-22-000718 |
| 2022-05-1216:10 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001079973-22-000575 |
| 2022-03-3116:03 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001079973-22-000372 |
| 2022-01-2517:09 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001079973-22-000098 |
| 2022-01-1216:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001079973-22-000044 |
| 2021-12-0616:05 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001079973-21-001196 |
| 2021-12-0317:12 ET | SC 13D | Ownership report, active investor | 0001079973-21-001193 |
| 2021-12-0318:45 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001079973-21-001182 |
| 2021-11-2616:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001553350-21-001109 |
| 2021-11-1716:44 ET | S-1/A | Registration statement, amended | 0001079973-21-001170 |
| 2021-11-1013:50 ET | S-1/A | Registration statement, amended | 0001079973-21-001119 |
| 2021-10-1916:57 ET | S-1 | Registration statement | 0001079973-21-001049 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 12:11 ET. Listed shows no prices and gives no investment advice.